PART I Unless the context otherwise requires, for purposes of this section, the terms we, us, our, our Company, the Company or Senti refer to Senti Biosciences, Inc. and its subsidiaries. Overview We are a clinical-stage biotechnology company developing next-generation cell and gene therapies engineered with our gene circuit platform technologies for patients living with incurable diseases. Our mission is to create a new generation of smarter medicines that outsmart complex diseases using novel ...
expected 2026-11-19
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-27 | 2025-12-31 | 0001628280-26-021580 | EDGAR | 114K words |
| 2025-03-20 | 2024-12-31 | 0001854270-25-000042 | EDGAR | 138K words |
| 2024-03-21 | 2023-12-31 | 0001854270-24-000029 | EDGAR | 115K words |
| 2023-03-22 | 2022-12-31 | 0001854270-23-000033 | EDGAR | 118K words |
| 2022-03-07 | 2021-12-31 | 0001193125-22-067994 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-08-14 | 2026-06-30 | 0001628280-26-057110 | EDGAR | 33K words |
| 2025-11-13 | 2025-09-30 | 0001628280-25-052125 | EDGAR | 73K words |
| 2025-08-07 | 2025-06-30 | 0001854270-25-000090 | EDGAR | 71K words |
| 2025-05-06 | 2025-03-31 | 0001854270-25-000065 | EDGAR | 70K words |
| 2024-11-14 | 2024-09-30 | 0001854270-24-000116 | EDGAR | 79K words |
| 2024-08-13 | 2024-06-30 | 0001854270-24-000101 | EDGAR | 77K words |
| 2024-05-09 | 2024-03-31 | 0001854270-24-000052 | EDGAR | 74K words |
| 2023-11-14 | 2023-09-30 | 0001854270-23-000129 | EDGAR | 87K words |
| 2023-08-11 | 2023-06-30 | 0001854270-23-000105 | EDGAR | 80K words |
| 2023-05-09 | 2023-03-31 | 0001854270-23-000064 | EDGAR | 76K words |
| 2022-11-10 | 2022-09-30 | 0001854270-22-000043 | EDGAR | — |
| 2022-08-15 | 2022-06-30 | 0001854270-22-000019 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-09-24 | 0001628280-26-063369 | EDGAR | 1K words |
| 2026-09-04 | 0001628280-26-060600 | EDGAR | 31K words |
| 2026-09-02 | 0001628280-26-060124 | EDGAR | 3K words |
| 2026-08-20 | 0001628280-26-058258 | EDGAR | 1K words |
| 2026-07-15 | 0001628280-26-048248 | EDGAR | 3K words |
| 2026-04-01 | 0001628280-26-022824 | EDGAR | 1K words |
| 2026-03-27 | 0001628280-26-021578 | EDGAR | 2K words |
| 2026-03-19 | 0001628280-26-019789 | EDGAR | 1K words |
| 2025-12-09 | 0001628280-25-055953 | EDGAR | 6K words |
| 2025-11-13 | 0001628280-25-052083 | EDGAR | 2K words |
110 total filings indexed. 83 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001854270 |
| Ticker | SNTI |
| Exchange | Nasdaq |
| SIC | 2836: Biological Products, (No Diagnostic Substances) |
| Incorporated | DE |
| Website | https://www.sentibio.com |
| Listed | 2022-06-09 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/SNTI (~200 tokens, structured JSON with cryptographic provenance)